We are live on ! Find out more
ECM

Ensemble Capital Management Portfolio holdings

AUM $1.18B
1-Year Est. Return 41.81%
This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+41.81%
3 Year Est. Return
+36.2%
5 Year Est. Return
+128.75%
10 Year Est. Return
+329.7%
AUM
$249M
AUM Growth
+$22.4M
Cap. Flow
+$1.47M
Cap. Flow %
0.59%
Top 10 Hldgs %
55.54%
Holding
52
New
1
Increased
18
Reduced
22
Closed
1

Sector Composition

Rank Sector Weight
1 Energy 21.43%
2 Financials 19.29%
3 Technology 18.1%
4 Healthcare 9.02%
5 Industrials 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETP
51
DELISTED
Energy Transfer Partners, L.P.
ETP
$226K 0.09%
+6,000
New +$207K
TEVA icon
52
Teva Pharmaceutical Industries Limited
TEVA
$45.7B
– –
-39,145
Closed -$1.48M

Similar funds

Ensemble Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Ensemble Capital Management held 52 positions worth $249M, up 9.9% from $226M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 3.8%. Ensemble Capital Management opened 1 new position and exited 1, leaving the 52-position portfolio largely intact.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

  • Ensemble Capital Management's largest Q4 2013 buy was Energy Transfer Partners, L.P.: 6,000 shares worth $226K.
  • Ensemble Capital Management added most to TransDigm Group in Q4 2013, an estimated $3.9M increase.
  • Ensemble Capital Management's biggest Q4 2013 reduction was KBR, cutting an estimated $3.24M.
  • Ensemble Capital Management fully exited Teva Pharmaceutical Industries Limited in Q4 2013, selling an estimated $1.48M.
  • Ensemble Capital Management's ten largest holdings make up 56% of its $249M portfolio in Q4 2013.
  • Ensemble Capital Management opened 1 new position and closed 1 in Q4 2013.
  • Ensemble Capital Management's portfolio value rose 9.9% quarter-over-quarter to $249M.

Based on Ensemble Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.